Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study
Published inThrombosis and haemostasis, vol. 114, no. 3, p. 645-650
Publication date2015
Abstract
Affiliation
Research group
Citation (ISO format)
WEITZ, J I et al. Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study. In: Thrombosis and haemostasis, 2015, vol. 114, n° 3, p. 645–650. doi: 10.1160/TH15-02-0131
Main files (1)
Article (Published version)
Identifiers
- PID : unige:75136
- DOI : 10.1160/TH15-02-0131
- PMID : 25994838
ISSN of the journal0340-6245